(En anglais)
A flood of interest in Alzheimer’s research. A flurry of action in AI-enabled drug discovery. Payers coming to grips with pricey cell and gene therapies. And a cadre of drugmakers looking to go carbon-neutral as DEI measures come to the fore.
We’ll delve into all these subjects and more on June 29-30, 2022, at the Fierce Biotech Next Gen virtual event.